New Therapeutic Developments in Urothelial Cancer: Clinical Trial Evidence and Expert Guidance
The goal of this activity is to improve the knowledge, confidence, competence, and performance of learners to integrate new agents and recent findings into the treatment of patients with urothelial cancer.
Category
  • Bladder Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentations from the NCCN 2020 Congress Series: Breast Cancer
Breast cancer continues to be the second most common cause of cancer death in women in the United States. Results from numerous clinical trials continue to expand diagnostic/prognostic tools, therapeutic options, and supportive care strategies.
Category
Format
Credits
Current Topics in Management of Non-Muscle Invasive Bladder Cancer
Non–muscle invasive bladder cancer (NMIBC) is the most commonly diagnosed form of bladder cancer. Better understanding of recommended treatment strategies during a bacillus Calmette Guérin (BCG) shortage, as well as familiarity with novel treatment options that may be on the horizon, will help educate clinicians on how to optimally treat NMIBC.
Category
  • Bladder Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages